Jay Olson
Stock Analyst at Oppenheimer
(0.91)
# 2122
Out of 5,344 analysts
294
Total ratings
33.52%
Success rate
-1.44%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
JSPR Jasper Therapeutics | Maintains: Outperform | 80 65 | 4.79 | 1256.99% | 5 | May 15, 2025 | |
INO Inovio Pharmaceutica... | Maintains: Outperform | 15 13 | 1.96 | 563.27% | 3 | May 14, 2025 | |
RVMD Revolution Medicines | Maintains: Outperform | 70 75 | 39.75 | 88.68% | 9 | May 8, 2025 | |
IMRX Immuneering | Maintains: Outperform | 25 21 | 1.54 | 1263.64% | 2 | May 7, 2025 | |
NKTR Nektar Therapeutics | Upgrades: Outperform | 6 | 0.65 | 823.08% | 6 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 42 | 13.44 | 212.5% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 58 62 | 6.58 | 842.25% | 11 | Feb 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | 41 33 | 42.38 | -22.13% | 6 | Jan 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 40 | 9.19 | 335.26% | 9 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 20 | 1.6 | 1150% | 2 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 270 255 | 125.84 | 102.64% | 21 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | 9 8 | 6.54 | 22.32% | 8 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 81 82 | 64.28 | 27.57% | 13 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 375 350 | 267.39 | 30.89% | 10 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 10 | 3.02 | 231.13% | 4 | Oct 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 138 138 | 27.02 | 410.73% | 8 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 | n/a | n/a | 6 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 8 | 1.79 | 346.93% | 1 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 48 | 8.07 | 494.8% | 3 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 380 380 | 272.08 | 39.66% | 21 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 216 219 | 120.19 | 82.21% | 14 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | 12 12 | 1.55 | 674.19% | 6 | Jun 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 18 | 2.91 | 518.56% | 5 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 10 | 0.91 | 998.9% | 5 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 102 95 | 36.89 | 157.52% | 6 | May 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | 19 19 | 22 | -13.64% | 14 | May 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | n/a | n/a | 1 | Apr 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 72 75 | 32.97 | 127.48% | 3 | Apr 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 9 | 0.3 | 2900% | 4 | Mar 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | n/a | n/a | n/a | 6 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 120 50 | 1.02 | 4801.96% | 4 | Nov 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | 25 21 | 5.81 | 261.45% | 9 | Nov 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Perform | 16 | n/a | n/a | 1 | Oct 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 56 62 | n/a | n/a | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 16 | n/a | n/a | 4 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 280 | n/a | n/a | 4 | May 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 210 229 | n/a | n/a | 8 | Mar 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Feb 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Nov 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Oct 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | Oct 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | 45 55 | n/a | n/a | 3 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 71 | n/a | n/a | 1 | Oct 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | 124 46 | n/a | n/a | 4 | Jun 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | 375 30 | n/a | n/a | 3 | Apr 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | 40 17 | n/a | n/a | 3 | Jan 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | 68 85 | n/a | n/a | 4 | Nov 25, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 84 | 20.37 | 312.37% | 1 | Mar 20, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | 2160 2520 | n/a | n/a | 2 | Jan 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 3 | Jul 11, 2017 |